Pegylated interferon alfa and ribavirin for children with chronic hepatitis C

World Journal of Gastroenterology

Volumn 19, Issue 7, 2013, Pages 1098-1103

  Rosen, Irit ^a   Kori, Michal ^b   Adiv, Orly Eshach ^a   Yerushalmi, Baruch ^c   Zion, Nataly ^a   Shaoul, Ron ^a  

^a MEYER CHILDREN S HOSPITAL   (Israel)

^b KAPLAN MEDICAL CENTER   (Israel)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Children; Hepatitis C virus; Interferon alfa; Ribavirin; Sustained viral response

Indexed keywords

ALKALINE PHOSPHATASE; BILIRUBIN; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RIBAVIRIN; VIRUS RNA;

ADOLESCENT; ADULT; ANEMIA; ANOREXIA; ARTICLE; ASEPTIC MENINGITIS; CHILD; CLINICAL ARTICLE; COMORBIDITY; DRUG WITHDRAWAL; FAT NECROSIS; FEMALE; FEVER; FLU LIKE SYNDROME; FOLLOW UP; HAIR LOSS; HEADACHE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HYPERBILIRUBINEMIA; INCIDENCE; LEUKOCYTE COUNT; LEUKOPENIA; LIVER HISTOLOGY; LYMPHADENOPATHY; MALAISE; MALE; MYALGIA; NEUTROPENIA; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; RASH; RETROSPECTIVE STUDY; SCHOOL CHILD; SIDE EFFECT; SOMNOLENCE; THROMBOCYTOPENIA; TREATMENT RESPONSE; VIRUS LOAD; WEIGHT REDUCTION;

EID: 84874362817     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i7.1098     Document Type: Article

References (26)

1. Guido M, Rugge M, Jara P, Hierro L, Giacchino R, Larrauri J, Zancan L, Leandro G, Marino CE, Balli F, Bagni A, Timitilli A, Bortolotti F. Chronic hepatitis C in children: the pathological and clinical spectrum. Gastroenterology 1998; 115: 1525-1529. [PMID: 9834281 DOI: 10.1016/S0016-5085(98)70032-0]
2. Chang MH, Ni YH, Hwang LH, Lin KH, Lin HH, Chen PJ, Lee CY, Chen DS. Long term clinical and virologic outcome of primary hepatitis C virus infection in children: a prospective study. Pediatr Infect Dis J 1994; 13: 769-773. [PMID: 7808843 DOI: 10.1097/00006454-199409000-00003]
3. Vogt M, Lang T, Frösner G, Klingler C, Sendl AF, Zeller A, Wiebecke B, Langer B, Meisner H, Hess J. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening. N Engl J Med 1999; 341: 866-870. [PMID: 10498458 DOI: 10.1056/NEJM199909163411202]
4. Hepatitis C virus infection. American Academy of Pediatrics. Committee on Infectious Diseases. Pediatrics 1998; 101: 481-485. [PMID: 9499195]
5. Ades AE, Parker S, Walker J, Cubitt WD, Jones R. HCV prevalence in pregnant women in the UK. Epidemiol Infect 2000; 125: 399-405. [PMID: 11117964 DOI: 10.1017/S0950268899004598]
6. Gerner P, Wirth S, Wintermeyer P, Walz A, Jenke A. Prevalence of hepatitis C virus infection in children admitted to an urban hospital. J Infect 2006; 52: 305-308. [PMID: 16473408 DOI: 10.1016/j.jinf.2005.04.004]
7. Bortolotti F, Verucchi G, Cammà C, Cabibbo G, Zancan L, Indolfi G, Giacchino R, Marcellini M, Marazzi MG, Barbera C, Maggiore G, Vajro P, Bartolacci S, Balli F, Maccabruni A, Guido M. Long-term course of chronic hepatitis C in children: from viral clearance to end-stage liver disease. Gastroenterology 2008; 134: 1900-1907. [PMID: 18439604 DOI: 10.1053/j.gastro.2008.02.082]
8. European Paediatric Hepatitis C Virus Network. Three broad modalities in the natural history of vertically acquired hepatitis C virus infection. Clin Infect Dis 2005; 41: 45-51. [PMID: 15937762 DOI: 10.1086/430601]
9. Goodman ZD, Makhlouf HR, Liu L, Balistreri W, Gonzalez-Peralta RP, Haber B, Jonas MM, Mohan P, Molleston JP, Murray KF, Narkewicz MR, Rosenthal P, Smith LJ, Robuck PR, Schwarz KB. Pathology of chronic hepatitis C in children: liver biopsy findings in the Peds-C Trial. Hepatology 2008; 47: 836-843. [PMID: 18167062 DOI: 10.1002/hep.22094]
10. Guido M, Bortolotti F, Leandro G, Jara P, Hierro L, Larrauri J, Barbera C, Giacchino R, Zancan L, Balli F, Crivellaro C, Cristina E, Pucci A, Rugge M. Fibrosis in chronic hepatitis C acquired in infancy: is it only a matter of time? Am J Gastroenterol 2003; 98: 660-663. [PMID: 12650803 DOI: 10.1111/ j.1572-0241.2003.07293.x]
11. Freeman AJ, Dore GJ, Law MG, Thorpe M, Von Overbeck J, Lloyd AR, Marinos G, Kaldor JM. Estimating progression to cirrhosis in chronic hepatitis C virus infection. Hepatology 2001; 34: 809-816. [PMID: 11584380 DOI: 10.1053/ jhep.2001.27831]
12. González-Peralta RP, Langham MR, Andres JM, Mohan P, Colombani PM, Alford MK, Schwarz KB. Hepatocellular carcinoma in 2 young adolescents with chronic hepatitis C. J Pediatr Gastroenterol Nutr 2009; 48: 630-635. [PMID: 19412012 DOI: 10.1097/MPG.0b013e318170af04]
13. Hu J, Doucette K, Hartling L, Tjosvold L, Robinson J. Treatment of hepatitis C in children: a systematic review. PLoS One 2010; 5: e11542. [PMID: 20644626 DOI: 10.1371/journal. pone.0011542]
14. Wirth S, Ribes-Koninckx C, Calzado MA, Bortolotti F, Zancan L, Jara P, Shelton M, Kerkar N, Galoppo M, Pedreira A, Rodriguez-Baez N, Ciocca M, Lachaux A, Lacaille F, Lang T, Kullmer U, Huber WD, Gonzalez T, Pollack H, Alonso E, Broue P, Ramakrishna J, Neigut D, Valle-Segarra AD, Hunter B, Goodman Z, Xu CR, Zheng H, Noviello S, Sniukiene V, Brass C, Albrecht JK. High sustained virologic response rates in children with chronic hepatitis C receiving peginterferon alfa-2b plus ribavirin. J Hepatol 2010; 52: 501-507. [PMID: 20189674 DOI: 10.1016/j.jhep.2010.01.016]
15. Schwarz KB, Gonzalez-Peralta RP, Murray KF, Molleston JP, Haber BA, Jonas MM, Rosenthal P, Mohan P, Balistreri WF, Narkewicz MR, Smith L, Lobritto SJ, Rossi S, Valsamakis A, Goodman Z, Robuck PR, Barton BA. The combination of ribavirin and peginterferon is superior to peginterferon and placebo for children and adolescents with chronic hepatitis C. Gastroenterology 2011; 140: 450-458.e1. [PMID: 21036173 DOI: 10.1053/j.gastro.2010.10.047]
16. Wirth S, Lang T, Gehring S, Gerner P. Recombinant alfainterferon plus ribavirin therapy in children and adolescents with chronic hepatitis C. Hepatology 2002; 36: 1280-1284. [PMID: 12395341 DOI: 10.1053/jhep.2002.36495]
17. Davison SM, Kelly DA. Management strategies for hepatitis C virus infection in children. Paediatr Drugs 2008; 10: 357-365. [PMID: 18998746 DOI: 10.2165/0148581-200810060-00003]
18. Palumbo E. Treatment for chronic hepatitis C in children: a review. Am J Ther 2009; 16: 446-450. [PMID: 19262360 DOI: 10.1097/MJT.0b013e31818a88c5]
19. Ascione A, De Luca M, Tartaglione MT, Lampasi F, Di Costanzo GG, Lanza AG, Picciotto FP, Marino-Marsilia G, Fontanella L, Leandro G. Peginterferon alfa-2a plus ribavirin is more effective than peginterferon alfa-2b plus ribavirin for treating chronic hepatitis C virus infection. Gastroenterology 2010; 138: 116-122. [PMID: 19852964 DOI: 10.1053/ j.gastro.2009.10.005]
20. Awad T, Thorlund K, Hauser G, Stimac D, Mabrouk M, Gluud C. Peginterferon alpha-2a is associated with higher sustained virological response than peginterferon alfa-2b in chronic hepatitis C: systematic review of randomized trials. Hepatology 2010; 51: 1176-1184. [PMID: 20187106 DOI: 10.1002/hep.23504]
21. Jansen PL, Reesink HW. Antiviral effect of peginterferon alfa-2b and alfa-2a compared. J Hepatol 2006; 45: 172-173. [PMID: 16797101 DOI: 10.1016/j.jhep.2006.06.003]
22. Rumi MG, Aghemo A, Prati GM, D'Ambrosio R, Donato MF, Soffredini R, Del Ninno E, Russo A, Colombo M. Randomized study of peginterferon-alpha2a plus ribavirin vs peginterferon-alpha2b plus ribavirin in chronic hepatitis C. Gastroenterology 2010; 138: 108-115. [PMID: 19766645 DOI: 10.1053/j.gastro.2009.08.071]
23. Zeuzem S. Do differences in pegylation of interferon alfa matter? Gastroenterology 2010; 138: 34-36. [PMID: 19932662 DOI: 10.1053/j.gastro.2009.11.034]
24. Wirth S, Kelly D, Sokal E, Socha P, Mieli-Vergani G, Dhawan A, Lacaille F, Saint Raymond A, Olivier S, Taminiau J. Guidance for clinical trials for children and adolescents with chronic hepatitis C. J Pediatr Gastroenterol Nutr 2011; 52: 233-237. [PMID: 21076340 DOI: 10.1097/MPG.0b013e318 1f6f09c]
25. Wirth S, Pieper-Boustani H, Lang T, Ballauff A, Kullmer U, Gerner P, Wintermeyer P, Jenke A. Peginterferon alfa-2b plus ribavirin treatment in children and adolescents with chronic hepatitis C. Hepatology 2005; 41: 1013-1018. [PMID: 15793840 DOI: 10.1002/hep.20661]
26. Jonas MM, Balistreri WF, Gonzalez-Peralta RP, Haber B, Mohan P, Molleston JP, Murray KF, Narkewicz M, Rosenthal P, Schwarz KB, Smith LJ, Barton B, Shepherd JA, Robuck PR, Duggan C. Changes in body mass index and body composition in children treated with peginterferon for chronic hepatitis C in the PEDS-C trial. Hepatology 2009; 50: 636a-637a